Trials / Terminated
TerminatedNCT00579020
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
An Evaluation of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether Moxidex ophthalmic solution is safe and effective in treating marginal corneal infiltrates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin/dexamethasone phosphate ophthalmic solution | |
| DRUG | Moxifloxacin ophthalmic solution 0.5% | |
| DRUG | Dexamethasone phosphate solution, 0.1% |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2007-12-21
- Last updated
- 2012-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00579020. Inclusion in this directory is not an endorsement.